首页> 外文期刊>Cell biochemistry and biophysics >The Study of Different Approaches of Parecoxib Sodium Pretreatment on the Behavior of Rats with Neuropathic Pain
【24h】

The Study of Different Approaches of Parecoxib Sodium Pretreatment on the Behavior of Rats with Neuropathic Pain

机译:帕瑞昔布钠预处理对神经性疼痛大鼠行为的不同研究

获取原文
获取原文并翻译 | 示例
           

摘要

Our objective is to analyze and observe the different administration routes of parecoxib sodium pretreatment on the behavioral improvement of rats with neuropathic pain to provide the preclinical data of parecoxib sodium on neuropathic pain treatment. 30 SD rats were randomly divided into five groups, including model group, sham operation group, intrathecal injection group (IT group), intraperitoneal injection group (IP group), and perineural infiltration group (PI group). The rats in model group and three parecoxib sodium pretreatment groups received spinal nerve ligation (SNL). Heat pain test and 50 % paw mechanical withdrawal threshold test (50 % PMWT) were use to assess the responses after parecoxib sodium pretreatment. 50 % PMWT results of right foot in five groups had no statistical difference (P > 0.05); 50 % PMWT results of left and right feet in three parecoxib sodium pretreatment groups were obviously higher than SNL group at different time points, which was statistically different (P < 0.05); in comparison with three pretreatment groups, the data of left foot in IT group were obviously higher than PI group and IP group, and the comparison among three groups had significant difference (P < 0.05). However, the data of right foot had no significant difference among three groups (P > 0.05). Paw thermal withdrawal latency (PTWL) results of left and right feet in five groups had no significant difference before surgery (P > 0.05); after the establishment of neuropathic model, PTWL results in five groups were significantly decreased; however, PTWL results of left and right feet at 3 days after surgery in IT group were significantly higher than the two other pretreatment groups (P < 0.05); PTWL results of left and right feet at 7 and 14 days after surgery had no significant difference. Parecoxib sodium pretreatment can effectively improve the behaviors caused by neuropathic pain, and intrathecal injection is the most effective route of administration.
机译:我们的目的是分析和观察帕瑞昔布钠预处理对神经性疼痛大鼠行为改善的不同给药途径,以提供帕瑞昔布钠治疗神经性疼痛的临床前数据。将30只SD大鼠随机分为5组,分别为模型组,假手术组,鞘内注射组(IT组),腹腔内注射组(IP组)和神经浸润组(PI组)。模型组和三个帕瑞昔布钠预处理组的大鼠接受脊髓神经结扎(SNL)。热疼痛测试和50%爪爪机械退缩阈值测试(50%PMWT)用于评估帕瑞昔布钠预处理后的反应。五组右脚PMWT结果50%无统计学差异(P> 0.05三个帕瑞昔布钠预处理组左脚和右脚的PMWT结果在不同时间点均显着高于SNL组,差异有统计学意义(P <0.05);左脚和右脚的PMWT结果均显着高于SNL组。与3个预处理组比较,IT组左脚数据明显高于PI组和IP组,三组比较有显着性差异(P <0.05)。然而,三组之间右脚的数据没有显着差异(P> 0.05)。五组左脚和右脚的足爪热缩潜伏期(PTWL)结果在术前无显着性差异(P> 0.05)。建立神经病理模型后,五组患者的PTWL结果均明显下降;然而,IT组术后3天左右脚的PTWL结果显着高于其他两个预处理组(P <0.05)。术后7天和14天左右脚的PTWL结果无显着差异。帕瑞昔布钠预处理可以有效改善神经性疼痛引起的行为,鞘内注射是最有效的给药途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号